FACULTY

LI Jianming Lab

LI Jianming

Professor, Ph.D. Supervisor

  • E-mail:jianmingli@ncu.edu.cn

  • Address:Room 401, Medical Science and Technology Innovation Center

Biography
Research
Group Members
Publications

Graduated from the First Military Medical University in 1993 with a bachelor's degree in Clinical Medicine and obtained a Ph.D. in Medicine from the Third Military Medical University in 2002. From 2004 to 2012, served as Lecturer, Associate Professor, and then Professor and Doctoral Supervisor in the Department of Pathology at Southern Medical University and its affiliated Nanfang Hospital, where he also held the position of Deputy Head. In 2012, he was appointed Distinguished Professor and Doctoral Supervisor at Soochow University. Since 2016, he has been serving as Professor, Director, and Doctoral Supervisor in the Department of Pathology and the Center for Cellular and Molecular Diagnostics at Sun Yat-sen Memorial Hospital of Sun Yat-sen University. In July 2023, he assumed roles as Guest Professor at Nanchang University, Vice President of its First Affiliated Hospital, and Director of both the Pathology Center and the Breast Center, while continuing as Doctoral Supervisor.



Conducting in-depth research on the molecular pathology of digestive system tumors, this work focuses on novel early diagnostic technologies, as well as the screening of individualized therapeutic targets, drug development, clinical efficacy validation, and the innovation of clinical diagnosis and treatment methodologies. Emphasis is placed on elucidating the roles and molecular mechanisms of tumor susceptibility genes, key signaling pathways, tumor metabolism, and post-translational modifications in tumor initiation and progression. The objective is to identify actionable intervention targets and establish novel strategies for effectively eliminating tumor cells, thereby laying a foundation for the improved prevention and treatment of solid tumors.



  1. Zi-long Zhang, Xu Xu, Di Zhang, Song-song Zhao, Chu-yi Wang, Gui-lin Zhang, Wen-shu Chen, Jing-lin Liu, Hui-min Gong, Youlutuziayi Rixiati, Shi Li, Tong Shen*Jian-ming Li*. Targeting Erbin-mitochondria axis in platelets/megakaryocytes promotes B cell-mediated antitumor immunity. Cell Metab. 2024;36(3):541-556.e9.

  2. Li-Heng Che, Jing-Wen Liu, Jian-Ping Huo, Rong Luo, Rui-Ming Xu, Cai He, Yu-Qing Li, Ai-Jun Zhou, Piao Huang, Yong-Yu Chen, Wen Ni, Yun-Xia Zhou, Yuan-Yuan Liu, Hui-Yan Li, Rong Zhou, Hui Mo, Jian-Ming Li*. A single-cell atlas of liver metastases of colorectal cancer reveals reprogramming of the tumor microenvironment in response to preoperative chemotherapy. Cell Discov. 2021;7(1):80.

  3. Tong Shen, Jing-Lin Liu, Chu-Yi Wang, Youlutuziayi Rixiati, Shi Li, Ling-Dong Cai, Yuan-Yuan Zhao, Jian-Ming Li*. Targeting Erbin in B cells for therapy of lung metastasis of colorectal cancer. Signal Transduct Target Ther, 2021;6(1):115.

  4. Wen Ni, Hui Mo, Yuan-yuan Liu, Yuan-yuan Xu, Chao Qin, Yun-xia Zhou, Yu-hui Li, Yu-qing Li, Ai-jun Zhou, Su Yao, Rong Zhou, Jian-ping Huo, Li-heng Che*, Jian-Ming Li*. Targeting Cholesterol Biosynthesis Promotes Anti-tumor Immunity by Inhibiting Long Noncoding RNA SNHG29 Mediated YAP Activation. Mol Ther, 2021;29(10):2995-3010.

  5. Heng-li Ni, Yong-yu Chen, Wei Xia, Chu-yi Wang, Cai-hong Hu, Lina Sun, Wen Tang, Hong-xia Cui, Tong Shen, Yao Liu*Jian-Ming Li*. SATB2 defect promotes colitis and colitis-associated colorectal cancer by impairing Cl-/HCO3-exchange and homeostasis of gut microbiota. J Crohns Colitis2021;15(12): 2088–2102.

  6. Jing-Lin Liu, Chu-Yi Wang, Tian-Yu Cheng, Youlutuziayi Rixiati, Cheng Ji, Min Deng, Su Yao, Li-Hua Yuan, Yuan-Yuan Zhao, Tong Shen*Jian-Ming Li*. Circadian Clock Disruption Suppresses PDL1+ Intraepithelial B Cells in Experimental Colitis and Colitis-Associated Colorectal Cancer. Cell Mol Gastroenterol Hepatol, 2021;12(1):251-276.

  7. Hua Wu, Tian-Yu Yang, Yi Li, Wen-Long Ye, Feng Liu, Xiao-Shun He, Jing-Ru Wang, Wen-Juan Gan, Xiu-Ming Li, Shen Zhang, Yuan-Yuan Zhao, Jian-Ming Li*. Tumor Necrosis Factor Receptor–Associated Factor 6 promotes hepatocarcinogenesis by interacting with Histone Deacetylase 3 to enhance c-Myc gene expression and protein stability. Hepatology, 2020; 71(1) :148-163.

  8. Ying Li, Zheng-Yi Luo, Yu-Ying Hu, Yue-Wei Bi, Jian-Ming Yang, Wen-Jun Zou, Yun-Long Song, Shi Li, Tong Shen, Shu-Ji Li, Lang Huang, Ai-Jun Zhou, Tian-Ming Gao*Jian-Ming Li*. The gut microbiota regulates autism-like behavior by mediating vitamin B6 homeostasis in EphB6-deficient mice. Microbiome, 2020;8(1):120.

  9. Liang-Yan Chen, Lian Wang, Yue-Xiang Ren, Zheng Pang, Yao Liu, Xiao-Dong Sun, Jian Tu, Zheng Zhi, Yan Qin, Li-Na Sun*Jian-Ming Li*. The circular RNA circ-ERBIN promotes growth and metastasis of colorectal cancer by miR-125a-5p and miR-138-5p/4EBP-1 mediated cap-independent HIF-1α translation. Mol Cancer. 2020;19(1):164.